NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Apr 24, 2024 $0.135 +1.73% $0.137 V 98.32% 1
Apr 24, 2024 $0.126 -5.30% $0.137 X 91.53% 0
Apr 24, 2024 $0.128 -3.31% $0.137 X 93.45% 0
JS JS Pro
Apr 12, 2024 $0.121 -2.42% $0.125 X 96.72% 0
Apr 12, 2024 $0.132 +6.35% $0.125 V 94.59% 1
Apr 12, 2024 $0.129 +3.97% $0.125 V 96.95% 1
JS JS Pro
Apr 10, 2024 $0.128 -2.81% $0.128 V 99.77% 6
Apr 10, 2024 $0.140 +6.28% $0.128 X 90.90% 0
Apr 10, 2024 $0.127 -3.93% $0.128 V 98.62% 2
JS JS Pro
Apr 8, 2024 $0.125 -3.92% $0.135 X 92.94% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE